Roche Diagnostics GmbH (manufacturing of unpackaged product, primary packaging, secondary packaging, quality control testing and batch release)
UkraineAll drugs from this manufacturer
-
The drug is used to treat various types of cancer, including metastatic colorectal cancer, breast cancer, non-small cell lung cancer, renal cell carcinoma, epithelial cancer of the ovaries and fallopian tubes, primary peritoneal cancer, cervical cancer, and recurrent glioblastoma.
Dosage form: concentrate for infusion solution
Active substance Dosage bevacizumab 25 mg/ml ATC: L01FG01